SPECIAL NOTICE
A -- Absorption Distribution Metabolism Elimination (ADME) Evaluation of Novel Therapeutic Candidates
- Notice Date
- 9/14/2017
- Notice Type
- Special Notice
- NAICS
- #541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH-17-T-0282
- Archive Date
- 12/14/2017
- Point of Contact
- Sharon R. Smith, Phone: 3016191352
- E-Mail Address
-
sharon.r.smith.civ@mail.mil
(sharon.r.smith.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- This is a NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT. The U.S. Army Medical Research Acquisition Activity (USAMRAA), on behalf of the USArmy Medical Research Institute of Infectious Diseases (USAMRIID) intends to solicit and negotiate with only one source, University of Florida located at 207 Grinter Hall, Gainesville, FL 32611. NAICS Code 541712, Size Standard Size 1,000 employees FAR citation is 10 U.S.C. 2304(c) (1). The statutory authority permitting other than full and open competition is FAR 6.302-1(a)(2)(iii)(A) and (B), for only one responsible source and no other supplies or services will satisfy agency requirements and that (1) substantial duplication of cost to the Government is not expected to be recovered through competition or (2) unacceptable delays in filling agency requirements.for the purposes of issuing a Firm-Fixed Price contract. The following services will be procured: The requirement is to continue research and development services for statistical analysis of pharmacokinetic nonhuman primate study data involving antibiotic effectiveness against various select agents. This includes providing Subject Matter Expertise (SME) to contribute toward further defining processes required to perform the statistical analysis of the nonhuman primate pharmacokinetic study sample data to indicate human equivalent dosing for potential submission to the FDA for human use against select agents. The period of performance will be one base year and four option years. There are no solicitation documents available. Contractors interested in this requirement should submit a complete capability package within the closing date stated below. The package must provide clear and convincing evidence that they can meet the Government's requirement. All information shall be furnished at no cost or obligation to the Government. Responses must be received no later than 10:00 p.m., Eastern Daylight Time, 19 September 2017. Responses should be submitted electronically to sharon.r.smith.civ@mail.mil. This notice of intent is not a request for competitive proposals; however, the government will consider all responses received by the response date stated above. A determination by the Government not to compete this acquisition based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. TELEPHONE REQUEST WILL NOT BE HONORED.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH-17-T-0282/listing.html)
- Record
- SN04678848-W 20170916/170914233054-a8f929ecaadfa0d8944ee969b5d01c6b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |